Skip to content
healthcare.dev

Cisatracurium

NDC 63323-418, CISATRACURIUM BESYLATE, injection, solution, from Fresenius Kabi USA, LLC.

Product NDC
63323-418
Status
Listed
Labeler
Fresenius Kabi USA, LLC
Dosage form
INJECTION, SOLUTION
Route
INTRAVENOUS
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA203182
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/63323-418 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • CISATRACURIUM BESYLATE10 mg/mL

Pharmacologic classes

Neuromuscular Nondepolarizing Blockade [PE]; Nondepolarizing Neuromuscular Blocker [EPC]

Package NDCNDC-11Package
63323-418-206332304182010 VIAL in 1 CARTON (63323-418-20) / 20 mL in 1 VIAL (63323-418-01)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/f78a07e2-0d3b-4460-b29e-8c10c90afbda

Use it

Look up 63323-418 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/63323-418 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 63323-418. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.